SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
BASF Se (BASFY) trades at a trailing P/E of 36.0, forward P/E of 25.4. Trailing earnings yield is 2.78%, forward earnings yield 3.94%. PEG 1.62.
Criteria proven by this page:
- VALUE (40/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 25.4 (down from trailing 36.0) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.62 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 2.78% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.94% as earnings recover.
Overall SharesGrow Score: 53/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
40/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BASFY
Valuation Multiples
P/E (TTM)36.0
Forward P/E25.4
PEG Ratio1.62
Forward PEG0.61
P/B Ratio0.00
P/S Ratio0.99
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.44
Forward EPS (Est.)$0.62
Book Value / Share$0.00
Revenue / Share$16.02
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.78%
Forward Earnings Yield3.94%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.10 |
$57.55B |
$4.06B |
7% |
| 2017 |
$1.65 |
$64.48B |
$6.08B |
9.4% |
| 2018 |
$1.28 |
$62.68B |
$4.71B |
7.5% |
| 2019 |
$0.69 |
$59.32B |
$2.55B |
4.3% |
| 2020 |
$-0.40 |
$59.15B |
$-1.47B |
-2.5% |
| 2021 |
$1.50 |
$78.6B |
$5.52B |
7% |
| 2022 |
$-0.11 |
$87.33B |
$-391M |
-0.4% |
| 2023 |
$0.06 |
$68.9B |
$225M |
0.3% |
| 2024 |
$0.36 |
$65.26B |
$1.3B |
2% |
| 2025 |
$0.44 |
$57.3B |
$1.56B |
2.7% |
